Daniel Levin

Title: The Innovative Contributions of Daniel Levin

Introduction

Daniel Levin is a notable inventor based in Poynton, GB. He has made significant contributions to the field of chemistry, particularly in the synthesis of complex organic compounds. His work has implications in various applications, including pharmaceuticals.

Latest Patents

Levin holds a patent for a process titled "Process for asymmetric synthesis of substituted 1,4-dihydropyridines." This innovative process involves reacting a vinylogous amide with an α,β-unsaturated ketone in the presence of a silicon compound. The reaction results in the formation of a 1,5-diketone, which is subsequently converted into a 1,4-dihydropyridine. The method allows for the synthesis of asymmetric substituted 1,4-dihydropyridines by preparing an asymmetric vinylogous amide through the reaction of a 1,3-cyclohexanedione with a substantially homo-chiral phenylethylamine. This advancement in asymmetric synthesis is crucial for developing new pharmaceuticals.

Career Highlights

Daniel Levin is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to innovative research and development in the pharmaceutical sector. Levin's expertise in organic chemistry has positioned him as a valuable asset in the field.

Collaborations

Levin has collaborated with notable colleagues, including Ian Patel and Ian Ashworth. These collaborations have fostered a productive environment for innovation and have led to advancements in their respective research areas.

Conclusion

Daniel Levin's contributions to the field of chemistry, particularly through his patent on the asymmetric synthesis of substituted 1,4-dihydropyridines, highlight his innovative spirit and dedication to advancing pharmaceutical research. His work continues to influence the development of new compounds that can have significant impacts in various applications.